Dual Chamber Prefilled Syringes Market: Safety Prefilled Syringes will Account for nearly 30% of Revenue Share – Scrutinized Report by Fact.MR

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

The mass technological transformation of the global healthcare industry has left key market participants struggling to traverse the complexities of medical and life sciences. Given the shifting dynamics of the global healthcare sector, pharma and biotech companies are taking measured efforts to improve patient outcomes in an effective manner, while keeping a careful watch on the bottom line.

According to Fact.MR’s recently collated research report, a spectacular growth has been envisaged for the global dual chamber prefilled syringes market in the forecast period (2017-2026). Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026-end.

For more insights, Request a Sample of Tricuspid Valve Repair Market Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=486

Dual Chamber Prefilled Syringes – Efficient Solution for Reconstituting Lyophilized Drugs during Administration

There has been an incessant requirement for reconstituting the lyophilized drugs during their administration, along with the growing necessity of tackling potential compliance and safety issues associated with the reconstitution. This has further led to the development of syringes that are capable of curtailing a number of steps required for the reconstitution of drugs and making them available for injection. Dual chamber prefilled syringes are the most efficient solution to cater to this requirement, as they enable immediate reconstitution within the syringe just prior to injection. Dual chamber prefilled syringes seek widespread utilization in storing biological substances and active pharmaceutical components, which cannot retain their stability for an extended duration. These devices enable the elimination of drug loss through maintenance of the drugs’ sterility prior to injection. Advancements in technology have resulted in improvements in the arrangement of liquid components in the syringes and injectors while attracting more patients in opting for these efficient & safe syringes.

Lyophilized drugs have represented a robust penetration worldwide in the recent past. Lyophilized drugs account for the largest share of all reconstitution-requiring injectable/infusible drugs. As a large number of injectable/infusible drugs have been developed for self-administration, special challenges are incurred for the drug developers. However, dual chamber prefilled syringes, which are particularly designed for simplifying reconstitution devoid of patient handling of diluent or drug, have become the mainstay option for delivering these drugs, meanwhile curtailing challenges faced by developers. With lyophilized drugs witnessing proliferated penetration, demand for dual chamber prefilled syringes will gain a significant upsurge in the foreseeable future.

Market Taxonomy

Region Product Type Product Material Sales Channel
North America Conventional Prefilled Syringes Glass Prefilled Syringes Hospital Pharmacies
Latin America Safety Prefilled Syringes Plastic Prefilled Syringes Retail Pharmacies
Europe Online Pharmacies
Japan
APEJ
MEA

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

 

For comprehensive insights on this market adoption, ask an analyst here

https://www.factmr.com/connectus/sample?flag=AE&rep_id=486

 

5 Key Takeaways from Fact.MR’s Report on Dual Chamber Prefilled Syringes Market for Forecast Period 2017-2026

  • Sales of dual chamber prefilled syringes are expected to record the fastest expansion in online pharmacies through 2026, trailed by retail pharmacies that will account for a relatively larger market revenue share than online pharmacies by 2026-end.
  • In terms of revenues, hospital pharmacies will continue to be the leading contributor to the global dual chamber prefilled syringes market.
  • Based on product material, glass prefilled syringes are anticipated to remain sought-after in the market, with sales projected to exceed US$ 2,000 Mn in revenues by 2026-end. Plastic prefilled syringes will exhibit a relatively higher CAGR in the market through 2026.
  • On the basis of product type, conventional prefilled syringes are expected to account for the lion’s share of the market from 2017 to 2026. Safety prefilled syringes will account for nearly 30% revenue share of the market through the forecast period.
  • North America is likely to prevail as the fast-expanding as well as the most lucrative market for dual chamber prefilled syringes, followed by Europe. Asia-Pacific excluding Japan (APEJ) will also account for a major chunk of the market’s revenue share during the forecast period.

With trends of surging demand for self-injection syringes and the development of advanced dual chamber prefilled syringes, major players in the market have directed their concentration toward product portfolio expansion. In this rapidly evolving and highly competitive market, several players are emphasizing on the essentiality of the up-to-date information, in a bid to monitor their performance and make critical decisions apropos to profitability & growth. Few market players are also focusing on improvements in the design of the dual chamber prefilled syringes in order to enhance the stability as well as safety of various sensitive drugs. Key players actively underpinning the market growth, as profiled by Fact.MR’s report, include Pfizer Inc., Amgen Inc., Boehringer Ingelheim GmbH, Nipro Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, Gerresheimer AG, Ypsomed Holding AG, West Pharmaceutical Services, Inc., Schott AG, Otsuka America Pharmaceutical, Inc., Credence MedSystems, Inc., Catalent, Inc., and Bespak Europe Ltd.

Explore Fact.MR’s Coverage on the Healthcare Domain

Auto Disable Syringes Market: A recent study by Fact.MR on the Auto Disable Syringes Market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Chromatography Syringes Market: Fact.MR’s extensive coverage on the chromatography syringes market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Syringe Market: The Syringe Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in the United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Research Insight:  https://www.factmr.com/report/486/dual-chamber-prefilled-syringes-market

Content Source: https://www.factmr.com/media-release/425/dual-chamber-prefilled-syringes-market

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles